Global Travel Insurance Market Exhibit to Grow at a CAGR of 9.74% by the end of 2021

Global Lupus Therapeutic Market


Lupus is a chronic autoimmune disease in which the body’s immune system becomes hyperactive and attacks normal, healthy tissue. This results in symptoms such as inflammation, swelling, and damage to joints, skin, kidneys, blood, the heart, and lungs. Systemic lupus erythematosus (SLE) is a major disease, which is followed by lupus nephritis at the later stages. Only one drug is approved specifically for the treatment of lupus disorders and the majority of other drugs are off-label based on symptoms. Due to a strong pipeline, the market is expected for more approved drugs for lupus disorders in future.

The analysts forecast the global lupus therapeutic market to grow at a CAGR of 9.74% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global lupus therapeutic market for 2017-2021. To calculate the market size, the report considers both generic and branded drug market.


Get Sample Report @  


The market is divided into the following segments based on geography:
• Americas

The Global Lupus Therapeutic Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• F.Hoffmann-La Roche
• GlaxoSmithKline
• Medlmmune
• Pfizer

Other prominent vendors
• ADMA Biologics
• Amgen
• Anthera Pharmaceuticals
• Bayer HealthCare
• Biogen
• Biotest
• Bristol-Myers Squibb
• Celgene
• Immunomedics
• Kedrion Biopharma
• LFB Group
• Merck
• Novartis
• Shire
• Takeda Pharmaceuticals

Market driver
• High prevalence rate
• For a full, detailed list, view our report

Market challenge
• Complexity of disease
• For a full, detailed list, view our report

Market trend
• Regenerative therapeutic technologies
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?


Complete Report Details @


Table of Contents -Major Key Points

PART 01: Executive summary 

PART 02: Scope of the report 

PART 03: Research Methodology 

PART 04: Introduction 

PART 05: An overview of lupus disease 

PART 06: Market landscape
• Market overview
• Five forces analysis

PART 07: Pipeline landscape 

PART 08: Market segmentation by drug class
• Anti-inflammatory drugs
• Corticosteroids
• Immunosuppressant drugs
• Antimalarial drugs
• BLyS-specific inhibitors
• Biologicals
• Others

PART 09: Geographical segmentation
• Lupus therapeutics market in Americas
• Lupus therapeutics market in EMEA
• Lupus therapeutics market in APAC

PART 10: Decision framework 

PART 11: Drivers and challenges
• Market drivers
• Market challenges

PART 12: Market trends
• Regenerative therapeutic technologies
• Inorganic growth strategies
• Government initiatives

PART 13: Vendor landscape
• Competitive scenario

PART 14: Key vendor analysis
• F. Hoffmann-La Roche
• GlaxoSmithKline
• MedImmune
• Pfizer
• Other prominent vendors 



Buy Now@  




Partner Relations & Marketing Manager

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)      

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, Industryresearch reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.



Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s